Assignee
NEUMIRNA THERAPEUTICS APS
DK·0 granted patents·4 pending applications·0 citations·filing 2022–2022
Top patents by PatentIndex Score
4 records- 0162US2025136990A1Antisense oligonucleotides targeting adenosine kinaseNEUMIRNA THERAPEUTICS APS·Filed 2022·Application pending·0 cites
- 0261US2024240188A1Antisense oligonucleotides targeting adenosine kinaseNEUMIRNA THERAPEUTICS APS·Filed 2022·Application pending·0 cites
- 0360US2024301414A1Microrna-134 inhibitorsNEUMIRNA THERAPEUTICS APS·Filed 2022·Application pending·0 cites
- 0460US2024182889A1Microrna-27b inhibitorsNEUMIRNA THERAPEUTICS APS·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NEUMIRNA THERAPEUTICS APS files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →